Lonazolac
From Wikipedia, the free encyclopedia
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.053.428 |
Chemical and physical data | |
Formula | C17H13ClN2O2 |
Molar mass | 312.75 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) |
Lonazolac is a nonsteroidal anti-inflammatory drug (NSAID).
References[]
Non-steroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA) | |
---|---|
pyrazolones / pyrazolidines | |
salicylates |
|
acetic acid derivatives and related substances | |
oxicams |
|
propionic acid derivatives (profens) |
|
n-arylanthranilic acids (fenamates) | |
COX-2 inhibitors (coxibs) |
|
other |
|
NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; #WHO-Essential Medicines; †withdrawn drugs; ‡veterinary use. | |
|
This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by . |
- v
- t
Retrieved from ""
Categories:
- Pyrazoles
- Nonsteroidal anti-inflammatory drugs
- Chloroarenes
- Musculoskeletal system drug stubs
Hidden categories:
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- ECHA InfoCard ID from Wikidata
- Articles with changed InChI identifier
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- All stub articles